Strategies for reversing drug resistance

Oncogene

Volumn 22, Issue 47 REV. ISS. 6, 2003, Pages 7512-7523

  Fojo, Tito ^a   Bates, Susan ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

ABC transporters; Apoptosis; Glutathione; Methylation; p53

Indexed keywords

4 (3 DIMETHYLAMINOPROPYLAMINO) 2 (4 METHOXYSTYRYL)QUINAZOLINE; 5 AZA 2' DEOXYCYTIDINE; ABC TRANSPORTER; ADENOVIRUS VECTOR; ANTIMYCIN A1; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; APOPTOSIS INDUCING FACTOR; AZACITIDINE; BH 3I; BUTHIONINE SULFOXIMINE; CISPLATIN; CYCLOSPORIN A; ELACRIDAR; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLYCOPROTEIN P; LANIQUIDAR; LIGASE INHIBITOR; MULTIDRUG RESISTANCE PROTEIN 1; OC 144093; ONYX 015; PIRMA 1; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN C JUN; PROTEIN MLH1; PROTEIN P53; RETROVIRUS VECTOR; RIBOZYME; TARIQUIDAR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALSPODAR; VIRUS VECTOR; ZOSUQUIDAR;

ACUTE MYELOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL DEATH; CLINICAL TRIAL; DNA SEQUENCE; DOWN REGULATION; DRUG ACCUMULATION; DRUG MEGADOSE; DRUG SCREENING; DRUG SENSITIVITY; DRUG TARGETING; DRUG TOLERABILITY; DRUG TRANSPORT; ENZYME SYNTHESIS; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; ION TRANSPORT; LUNG NON SMALL CELL CANCER; MULTIDRUG RESISTANCE; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN METHYLATION; REVIEW; SEQUENCE HOMOLOGY; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION INITIATION SITE; TUMOR REGRESSION; WILD TYPE;

APOPTOSIS; ATP-BINDING CASSETTE TRANSPORTERS; DNA METHYLATION; DRUG RESISTANCE, NEOPLASM; GLUTATHIONE; HUMANS; TUMOR SUPPRESSOR PROTEIN P53;

ADENOVIRIDAE; UNIDENTIFIED RETROVIRUS;

EID: 0344393732     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206951     Document Type: Review

References (141)

1. Adams JM and Cory S. (1998). Science, 281, 1322-1326.
2. Advani R, Saba HI, Tallman MS, Rowe JM, Wiernik PH, Ramek J, Dugan K, Lum B, Villena J, Davis E, Paietta E, Litchman M, Sikic BI and Greenberg PL. (1999). Blood, 93, 787-795.
3. Aebi S, Fink D, Gordon R, Kim HK, Zheng H, Fink JL and Howell SB. (1997). Cancer Res., 3, 1763-1767.
4. Aina OH, Sroka TC, Chen ML and Lam KS. (2002). Biopolymers, 66, 184-199.
5. Avendano C and Menendez JC. (2002). Curr. Med. Chem., 9, 159-193.
6. Bailey HH. (1998). Chem. Biol. Interact., 111-112, 239-254.
7. Bailey HH, Mulcahy RT, Tutsch KD, Arzoomanian RZ, Alberti D, Tombes MB, Wilding G, Pomplun M and Spriggs DR. (1994). J. Clin. Oncol., 12, 194-205.
8. Bartlett NL, Lum BL, Fisher GA, Brophy NA, Ehsan MN, Halsey J and Sikic BI. (1994). J. Clin. Oncol., 12, 835-842.
9. Barton CM and Lemoine NR. (1995). Br. J. Cancer, 71, 429-437.
10. Bender CM, Pao MM and Jones PA. (1998). Cancer Res., 58, 95-101.
11. Benderra Z, Trussardi A, Morjani H, Villa AM, Doglia SM and Manfait M. (2000). Eur. J. Cancer. 36, 428-434.
12. Bergelson JM, Krithivas A, Celi L, Droguett G, Horwitz MS, Wickham T, Crowell RL and Finberg RW. (1998). J. Virol., 72, 415-419.
13. Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A and McCormick F. (1996). Science, 274, 373-376.
14. Blagosklonny MV and El-Deiry WS. (1998). Int. J. Cancer, 75, 933-940.
15. Borst P, Evers R, Kool M and Wijnholds. (2000a). J. Natl. Cancer Inst., 92, 1295-1302.
16. Borst P, Zelcer N and van Helvoort A. (2000b). Biochim. Biophys. Acta, 1486, 128-144.
17. Boulay JL, Perruchoud AP, Reuter J, Bolliger C, Herrmann R and Rochlitz C. (2000). Cancer Gene Ther., 7, 1215-1219.
18. Bourdon JC, Renzing J, Robertson PL, Fernandes KN and Lane DP. (2002). J. Cell. Biol., 58, 235-246.
19. Bouvet M, Ellis LM, Nishizaki M, Fujiwara T, Liu W, Bucana CD, Fang B, Lee JJ and Roth JA. (1998). Cancer Res., 58, 2288-2292.
20. Bradshaw DM and Arceci RJ. (1998). J. Clin. Oncol., 16, 3674-3690.
21. Brown R, Hirst GL, Gallagher WM, McIlwrath AJ, Margison GP, van der Zee AG and Anthoney DA. (1997). Oncogene, 15, 45-52.
22. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR and Kley N. (1995). Nature, 377, 646-649.
23. Bykov VJ, Issaeva N, Shilov A, Hultcrantz M, Pugacheva E, Chumakov P, Bergman J, Wiman KG and Selivanova G. (2002). Nat. Med., 8, 282-288.
24. Chai J, Du C, Wu J-W, Kyin S, Wang X and Shi Y. (2000). Nature, 406, 855-862.
25. Chan JY, Chu AC and Fung KP. (2000). Life Sci., 67, 2117-2124.
26. Chan JY, Kong SK, Choy YM, Lee CY and Fung KP. (1999). Life Sci., 65, 63-70.
27. Childs S, Yeh RL, Hui D and Ling V. (1998). Cancer Res., 58, 4160-4167.
28. Clayman GL, Frank DK, Bruso PA and Goepfert H. (1999). Clin. Cancer Res., 5, 1715-1722.
29. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM and Deeley RG. (1992). Science, 258, 1650-1654.
30. Dai J, Weinberg RS, Waxman S and Jing Y. (1999). Blood, 93, 268-277.
31. Dameron KM, Volpert OV, Tainsky MA and Bouck N. (1994). Cold Spring Harb. Symp. Quant. Biol., 59, 483-489.
32. Dano K. (1973). Biochim. Biophys. Acta, 323, 466-483.
33. Dantzig AH, Shepard RL, Law KL, Tabas L, Pratt S, Gillespie JS, Binkley SN, Kuhfeld MT, Starling JJ and Wrighton SA. (1999). J. Pharmacol. Exp. Ther., 290, 854-862.
34. Dassow H, Lassner D, Remke H and Preiss R. (2000). Int. J. Clin. Pharmacol. Ther., 38, 209-216.
35. de Bruin M, Miyake K, Litman T, Robey R and Bates SE. (1999). Cancer Lett. 146, 117-126.
36. Dedoussis GV and Andrikopoulos NK. (2001). Eur. J. Cell. Biol., 80, 608-614.
37. Degterev A, Lugovskoy A, Cardone M, Mulley B, Wagner G, Mitchison T and Yuan J. (2001). Nat. Cell Biol., 3, 173-182.
38. Dix BR, Edwards SJ and Braithwaite AW. (2001). J. Virol., 75, 5443-5447.
39. Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK and Ross DD. (1998). Proc. Natl. Acad Sci. USA, 95, 15665-15670.
40. Durant ST, Morris MM, Illand M, McKay HJ, McCormick C, Hirst GL, Borts RH and Brown R. (1999). Curr. Biol., 9, 51-54.
41. Fakhrai H, Dorigo O, Shawler DL, Lin H, Mercola D, Black KL, Royston I and Sobol RE. (1996). Proc. Natl. Acad. Sci. USA, 93, 2909-2914.
42. Fechner H, Haack A, Wang H, Wang X, Eizema K, Pauschinger M, Schoemaker R, Veghel R, Houtsmuller A, Schultheiss HP, Lamers J and Poller W. (1999). Gene Therapy, 6, 1520-1535.
43. Fedeli L, Colozza M, Boschetti E, Sabalich I, Aristei C, Guerciolini R, Del Favero A, Rossetti R, Tonato M, Rambotti P and Davis S. (1989). Cancer, 64, 1805-1811.
44. Fernandez-Salas E, Suh KS, Speransky VV, Bowers WL, Levy JM, Adams T, Pathak KR, Edwards LE, Hayes DD, Cheng C, Steven AC, Weinberg WC and Yuspa SH. (2002). Mol. Cell. Biol., 22, 3610-3620.
45. Ferry DR, Traunecker H and Kerr DJ. (1996). Eur. J. Cancer, 32A, 1070-1081.
46. Fisher GA, Lum BL, Hausdorff J and Sikic BI. (1996). Eur. J. Cancer, 32, 1082-1088.
47. Fisher GA and Sikic BI. (1995). Hematol. Oncol. Clin. N. Am., 9, 363-382.
48. Ford JM and Hait WN. (1990). Pharmacol. Rev., 42, 155-195.
49. Foster BA, Coffey HA, Morin MJ and Rastinejad F. (1999). Science, 286, 2507-2510.
50. Gao Z, Gao Z, Fields JZ and Boman BM. (1999). Int. J. Cancer, 82, 346-352.
51. Gartenhaus RB, Prachand SN, Paniaqua M, Li Y and Gordon LI. (2002). Clin. Cancer Res., 8, 566-572.
52. Germann UA, Ford PJ, Shlyakhter D, Mason VS and Harding MW. (1997). Anticancer Drugs, 8, 141-155.
53. Glover AB, Leyland-Jones BR, Chun HG, Davies B and Hoth DF. (1987). Cancer Treat Rep., 71, 737-746.
54. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC and Anderson ME. (1992). Proc. Natl. Acad. Sci. USA, 89, 3070-3074.
55. Griffith OW and Meister A. (1979). J. Biol. Chem., 254, 7558-7560.
56. Hamel E. (2002). Biopolymers, 66, 142-160.
57. Heere-Ress E, Thallinger C, Lucas T, Schlagbauer-Wadl H, Wacheck V, Monia BP, Wolff K, Pehamberger H and Jansen B. (2002). Int. J. Cancer, 99, 29-34.
58. Hipfner DR, Deeley RG and Cole SP. (1999). Biochim. Biophys. Acta, 1461, 359-376.
59. Holm PS, Scanlon KJ and Dietel M. (1994). Br. J. Cancer, 70, 239-243.
60. Hsieh CL. (1994). Mol. Cell. Biol., 14, 5487-5494.
61. Huesker M, Folmer Y, Schneider M, Fulda C, Blum HE and Hafkemeyer P. (2002). Hepatology, 36, 874-884.
62. Irie A, Kijima H, Ohkawa T, Bouffard DY, Suzuki T, Curcio LD, Holm PS, Sassani A and Scanlon KJ. (1997). Adv. Pharmacol., 40, 207-257.
63. Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G and Keppler D. (1996). Cancer Res., 56, 988-994.
64. Juliano RL and Ling V. (1976). Biochim. Biophys. Acta, 455, 152-162.
65. Kerr DJ, Graham J, Cummings J, Morrison JG, Thompson GG, Brodie MJ and Kaye SB. (1986). Cancer Chemother. Pharmacol., 18, 239-242.
66. Khuri FR, Nemunaitis J, Ganly I, Arseneau J, Tannock IF, Romel L, Gore M, Ironside J, MacDougall RH, Heise C, Randlev B, Gillenwater AM, Bruso P, Kaye SB, Hong WK and Kirn DH. (2000). Nat. Med., 6, 879-885.
67. Kimura S, Maekawa T, Hirakawa K, Murakami A and Abe T. (1995). Cancer Res., 55, 1379-1384.
68. Klasa RJ, Gillum AM, Klem RE and Frankel SR. (2002). Antisense Nucleic Acid Drug Dev., 12, 193-213.
69. Kobayashi H, Dorai T, Holland JF and Ohnuma T. (1994). Cancer Res., 54, 1271-1275.
70. Kornblau SM, Estey E, Madden T, Tran HT, Zhao S, Consoli U, Snell V, Sanchez-Williams G, Kantarjian H, Keating M, Newman RA and Andreeff M. (1997). J. Clin. Oncol., 15, 1796-1802.
71. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE and Oltvai ZN. (1993). Semin. Cancer Biol., 4, 327-332.
72. Kowalski P, Stein U, Scheffer GL and Lage H. (2002). Cancer Gene Ther., 9, 579-586.
73. Kramer RA, Zakher J and Kim G. (1988). Science, 241, 694-697.
74. Lai GM, Moscow JA, Alvarez MG, Fojo AT and Bates SE. (1991). Int. J. Cancer, 49, 688-695.
75. Laing NM, Belinsky MG, Kruh GD, Bell DW, Boyd JT, Barone L, Testa JR and Tew KD. (1998). Cancer Res., 58, 1332-1337.
76. Lee EJ, George SL, Caligiuri M, Szatrowski TP, Powell BL, Lemke S, Dodge RK, Smith R, Baer M and Schiffer CA. (1999). J. Clin. Oncol., 17, 2831-2839.
77. Lehnert M, de Giuli R, Kunke K, Emerson S, Dalton WS and Salmon SE. (1996). Eur. J. Cancer, 32A, 862-867.
78. Lin Y, Ma W and Benchimol S. (2000). Nat. Genet., 26, 122-127.
79. List AF, Kopecky KJ, Willman CL, Head DR, Persons DL, Slovak ML, Dorr R, Karanes C, Hynes HE, Doroshow JH, Shurafa M and Appelbaum FR. (2001). Blood, 98, 3212-3220.
80. List AF, Spier C, Greer J, Wolff S, Hutter J, Dorr R, Salmon S, Futscher B, Baier M and Dalton W. (1993). J. Clin. Oncol., 11, 1652-1660.
81. Liu C, Qureshi IA, Ding X, Shan Y, Huang Y, Xie Y and Ji M. (1996). Clin. Sci. (Lond), 91, 93-98.
82. Loe DW, Deeley RG and Cole SP. (1998). Cancer Res., 58, 5130-5136.
83. Lorico A, Bertola A, Baum C, Fodstad O and Rappa G. (2002). Biochem. Biophys. Res. Commun., 291, 617-622.
84. Lowe SW, Ruley HE, Jacks T and Housman DE. (1993). Cell, 74, 957-967.
85. Lum BL, Kaubisch S, Yahanda AM, Adler KM, Jew L, Ehsan MN, Brophy NA, Halsey J, Gosland MP and Sikic BI. (1992). J. Clin. Oncol., 10, 1635-1642.
86. Mackay HJ, Cameron D, Rahilly M, Mackean MJ, Paul J, Kaye SB and Brown R. (2000). J. Clin. Oncol., 18, 87-93.
87. Maliepaard M, van Gastelen MA, Tohgo A, Hausheer FH, van Waardenburg RC, de Jong LA, Pluim D, Beijnen JH and Schellens JH. (2001). Clin. Cancer Res., 7, 935-941.
88. McCormick F. (2001). Nat. Rev. Cancer, 1, 130-141.
89. Millward MJ, Cantwell BM, Munro NC, Robinson A, Corris PA and Harris AL. (1993). Br. J. Cancer, 67, 1031-1035.
90. Mistry P, Stewart AJ, Dangerfield W, Okiji S, Liddle C, Bootle D, Plumb JA, Templeton D and Charlton P. (2001). Cancer Res., 61, 749-758.
91. Miyake H, Monia BP and Gleave ME. (2000). Int. J. Cancer, 86, 855-862.
92. Miyake K, Mickley L, Litman T, Zhan Z, Robey R, Cristensen B, Brangi M, Greenberger L, Dean M, Fojo T and Bates SE. (1999). Cancer Res., 59, 8-13.
93. Miyashita T and Reed JC. (1995). Cell, 80, 293-299.
94. Møller MB, Gerdes AM, Skjodt K, Mortensen LS and Pedersen NT. (1999). Clin. Cancer. Res., 5, 1085-1091.
95. Momparler RL, Cote S and Eliopoulos N. (1997). Leukemia, 11, 175-180.
96. Muller M, Meijer C, Zaman GJ, Borst P, Scheper RJ, Mulder NH, de Vries EG and Jansen PL. (1994). Proc. Natl. Acad. Sci. USA, 91, 13033-13037.
97. Nagata J, Kijima H, Hatanaka H, Asai S, Miyachi H, Abe Y, Yamazaki H, Nakamura M, Watanabe N, Mine T, Kondo T, Scanlon KJ and Ueyama Y. (2002). Int. J. Oncol., 21, 1021-1026.
98. Nagata J, Kijima H, Hatanaka H, Asai S, Miyachi H, Takagi A, Miwa T, Mine T, Yamazaki H, Nakamura M, Kondo T, Scanlon KJ and Ueyama Y. (2001). Biochem. Biophys. Res. Commun., 286, 406-413.
99. Nakano K and Vousden KH. (2001). Mol. Cell, 7, 683-694.
100. Nemunaitis J, Khuri F, Ganly I, Arseneau J, Posner M, Vokes E, Kuhn J, McCarty T, Landers S, Blackburn A, Romel L, Randlev B, Kaye S and Kirn D. (2001). J. Clin. Oncol., 19, 289-298.
101. Newman MJ, Rodarte JC, Benbatoul KD, Romano SJ, Zhang C, Krane S, Moran EJ, Uyeda RT, Dixon R, Guns ES and Mayer LD. (2000). Cancer Res., 60, 2964-2972.
102. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T and Tanaka N. (2000). Science, 288, 1053-1058.
103. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y and Taya Y. (2000). Cell, 102, 849-862.
104. Olie RA and Zangemeister-Wittke U. (2001). Drug Resist. Updates, 4, 9-15.
105. O'Neal WK, Zhou H, Morral N, Aguilar-Cordova E, Pestaner J, Langston C, Mull B, Wang Y, Beaudet AL and Lee B. (1998). Hum. Gene Ther., 9, 1587-1598.
106. Owen-Schaub LB, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang WW and Kruzel E et al. (1995). Mol. Cell. Biol., 15, 3032-3040.
107. Plumb JA, Strathdee G, Sludden J, Kaye SB and Brown R. (2000). Cancer Res., 60, 6039-6044.
108. Polyak K, Xia Y, Zweier JL, Kinzler KW and Vogelstein B. (1997). Nature, 389, 300-305.
109. Rabindran SK, Ross DD, Doyle LA, Yang W and Greenberger LM. (2000). Cancer Res., 60, 47-50.
110. Reed JC. (2000). Am. J. Pathol., 157, 1415-1430.
111. Relling MV. (1996). Ther. Drug Monit., 18, 350-356.
112. Rizk NP, Chang MY, El Kouri C, Seth P, Kaiser LR, Albelda SM and Amin KM. (1999). Cancer Gene Ther., 6, 291-301.
113. Robey R, Bakke S, Stein W, Meadows B, Litman T, Patil S, Smith T, Fojo T and Bates S. (1999). Blood, 93, 306-314.
114. Rochlitz CF. (2001). Swiss. Med. Weekly, 131, 4-9.
115. Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ, Hong WK, Komaki R, Lee JJ, Nesbitt JC, Pisters KM, Putnam JB, Schea R, Shin DM, Walsh GL, Dolormente MM, Han CI, Martin FD, Yen N, Xu K, Stephens LC, McDonnell TJ, Mukhopadhyay T and Cai D. (1996). Nat. Med., 2, 985-991.
116. Rowinsky EK, Smith L, Wang YM, Chaturvedi P, Villalona M, Campbell E, Aylesworth C, Eckhardt SG, Hammond L, Kraynak M, Drengler R, Stephenson Jr J, Harding MW and Von Hoff DD. (1998). J. Clin. Oncol., 16, 2964-2976.
117. Smit JJ, Schinkel AH, Oude Elferink RP, Groen AK, Wagenaar E, van Deemter L, Mol CA, Ottenhoff R, van der Lugt NM and van Roon MA. (1993). Cell, 75, 451-462.
118. Solary E, Witz B, Caillot D, Moreau P, Desablens B, Cahn JY, Sadoun A, Pignon B, Berthou C, Maloisel F, Guyotat D, Casassus P, Ifrah N, Lamy Y, Audhuy B, Colombat P and Harousseau JL. (1996). Blood, 88, 1198-1205.
119. Song S, Suzuki H, Kawai R, Tanaka C, Akasaka I and Sugiyama Y. (1998). Drug Metab. Dispos., 26, 1128-1133.
120. Sorrentino BP. (2002). Nat. Rev. Cancer, 2, 431-441.
121. Sparreboom A, Planting AS, Jewell RC, van der Burg ME, van der Gaast A, de Bruijn P, Loos WJ, Nooter K, Chandler LH, Paul EM, Wissel PS and Verweij J. (1999). Anticancer Drugs, 10, 719-728.
122. Stewart A, Steiner J, Mellows G, Laguda B, Norris D and Bevan P. (2000). Clin. Cancer Res., 6, 4186-4191.
123. Stewart AJ, Canitrot Y, Baracchini E, Dean NM, Deeley RG and Cole SP. (1996). Biochem. Pharmacol., 51, 461-469.
124. Strathdee G, MacKean MJ, Illand M and Brown R. (1999). Oncogene, 18, 2335-2341.
125. Swisher SG, Roth JA, Nemunaitis J, Lawrence DD, Kemp BL, Carrasco CH, Connors DG, El-Naggar AK, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Mack M, Merritt JA, Nguyen DM, Nesbitt JC, Perez-Soler R, Pisters KM, Putnam Jr JB, Richli WR, Savin M, Schrump DS, Shin DM, Shulkin A, Walsh GL, Wait J, Weill D and Waugh MKA. (1999). J. Natl. Cancer Inst., 91, 763-771.
126. Tamm I, Dorken B and Hartmann G. (2001). Lancet, 358, 489-497.
127. Tango Y, Fujiwara T, Itoshima T, Takata Y, Katsuda K, Uno F, Ohtani S, Tani T, Roth JA and Tanaka N. (2002). Hum Gene Ther., 13, 1373-1382.
128. Trump DL, Smith DC, Ellis PG, Rogers MP, Schold SC, Winer EP, Panella TJ, Jordan VC and Fine RL. (1992). J. Natl. Cancer Inst., 84, 1811-1816.
129. Tsuruo T, Iida H, Tsukagoshi S and Sakurai Y. (1983). Cancer Res., 43, 2267-2272.
130. Tzung SP, Kim KM, Basanez G, Giedt CD, Simon J, Zimmerberg J, Zhang KY and Hockenbery DM. (2001). Nat. Cell Biol., 3, 183-191.
131. Ueda K, Cardarelli C, Gottesman MM and Pastan I. (1987). Proc. Natl. Acad. Sci. USA, 84, 3004-3008.
132. Vahrmeijer AL, Hoetelmans RW, Mulder GJ, Schutrups J, van Vlierberghe RL, van de Velde CJ and van Dierendonck JH. (2000). Biochem. Pharmacol., 59, 1557-1562.
133. van Zuylen L, Sparreboom A, van der Gaast A, van der Burg ME, van Beurden V, Bol CJ, Woestenborghs R, Palmer PA and Verweij J. (2000). Clin. Cancer Res., 6, 1365-1371.
134. Vernhet L, Allain N, Bardiau C, Anger JP and Fardel O. (2000). Toxicology, 142, 127-134.
135. Vulevic B, Chen Z, Boyd JT, Davis Jr W, Walsh ES, Belinsky MG and Tew KD. (2001). Cancer Res., 61, 3339-3347.
136. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace Jr AJ, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, Buolamwini JK, van Osdol WW, Monks AP, Scudiero DA, Sausville EA, Zaharevitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE and Paull KD. (1999). Science, 275, 343-349.
137. Wilson WH, Jamis-Dow C, Bryant G, Balis FM, Klecker RW, Bates SE, Chabner BA, Steinberg SM, Kohler DR and Wittes RE. (1995). J. Clin. Oncol., 13, 1985-1994.
138. Yao K, Godwin AK, Ozols RF, Hamilton TC and O'Dwyer PJ. (1993). Cancer Res., 53, 3662-3666.
139. Yao KS, Godwin AK, Johnson SW, Ozols RF, O'Dwyer PJ and Hamilton TC. (1995). Cancer Res., 55, 4367-4374.
140. Yu J, Zhang L, Hwang PM, Kinzler KW and Vogelstein B. (2001). Mol. Cell, 7, 673-682.
141. Zangemeister-Wittke U, Leech SH, Olie RA, Simoes-Wust AP, Gautschi O, Luedke GH, Natt F, Haner R, Martin P, Hall J, Nalin CM and Stahel RA. (2000). Clin. Cancer Res., 6, 2547-2555.